Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines
2011

Osteopontin's Role in Hepatocellular Carcinoma

publication Evidence: moderate

Author Information

Author(s): Zhang Rihua, Pan Xiaolin, Huang Zuhu, Weber Georg F., Zhang Guoxin

Primary Institution: The First Affiliated Hospital of Nanjing Medical University

Hypothesis

This study investigates the effect of the SDF-1α/CXCR4 axis on expression and activity of MMP-2 induced by osteopontin.

Conclusion

Osteopontin up-regulates MMP-2 through the SDF-1α/CXCR4 axis, which may be a new therapeutic target for treating HCC progression.

Supporting Evidence

  • Recombinant human osteopontin significantly increased MMP-2 expression in hepatocellular carcinoma cells.
  • Inhibition of the SDF-1α/CXCR4 axis reduced MMP-2 expression and activity.
  • CXCR4-deficient cells showed decreased invasion in response to osteopontin.

Takeaway

Osteopontin helps cancer cells grow and spread by increasing a protein called MMP-2, which is important for cancer invasion.

Methodology

The study used Western blotting, gel zymography, and transwell assays to analyze the effects of osteopontin on MMP-2 expression and activity in hepatocellular carcinoma cell lines.

Limitations

The study was conducted using only two human hepatocellular carcinoma cell lines, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0023831

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication